Not applicableLooking for participantsNCT06075433
What this trial is testing
Efficacy and Safety of 1-year Duration of DAPT After GENOSS® DES Implantation in Patients with Coronary Artery Disease According to the Complex Higher-risk Procedure
Who this might be right for
Coronary Artery DiseasePercutaneous Coronary InterventionDual Antiplatelet Therapy
Genoss Co., Ltd. 1,000